July 24, 2012
Antu Dey of Novartis Vaccines & Diagnostics in Cambridge, Mass., talks with Fred Schaich about where we are in terms of HIV vaccine development. He compares the safety and efficacy of vaccine research in animal and human trials, and discusses the need for researchers to collaborate and how to progress vaccine research.
The video above has been cross-posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's blog to watch more video interviews from the conference.
|Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.|